In the field of cancer detection, technologies to analyze tumors using biomarkers circulating
in fluids such as blood have developed rapidly based on liquid biopsy. A proactive approach …

Nucleic acid-based cancer biomarkers (NABCBs) have emerged as a notable and
continuously captivating research focal point within the domain of oncology. As a result …

An accurate and robust method for quantifying the levels of circulating tumor DNA (ctDNA) is
vital if this potential biomarker is to be used for the early diagnosis of cancer. The analysis of …

Early detection and diagnostics are essential for the cure of cancer which has high mortality
rate globally. In recent decades, various methods such as mammography, computed …

Label-free biosensors which can be integrated into lab-on-a-chip platforms have the
advantage of using small volumes for rapid and inexpensive measurements contrary to label …

Electrochemical nucleic acid biosensor has demonstrated great promise in clinical
diagnostic tests, mainly because of its flexibility, high efficiency, low cost, and easy …

Molecular biology applications based on gold nanotechnology have revolutionary impacts,
especially in diagnosing and treating molecular and cellular levels. The combination of …

Liquid biopsy allows for the quick and noninvasive detection of tumor-associated
components. Various liquid biopsy components, which include circulating tumor cells, tumor …

Cancer has become one of the major diseases threatening human health and life.
Circulating tumor DNA (ctDNA) testing, as a practical liquid biopsy technique, is a promising …

Oncobiomarkers act as perfect indicators for cancer detection. The latest advances in the
field of early stage diagnosis of cancer reveal that sensitive and selective measurement of …